Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase 2023
Massively Parallel Sequencing for SARS-CoV-2 Detection and Surveillance
As the COVID-19 pandemic continues to evolve, more and more sequencing power is needed to obtain the most up-to-date information on the virus. This information help to construct the transmission routes and the profiles of the most recent variants, effectively supporting large-scale surveillance efforts and research on different mutations of the virus.
Parallel Sequencing (MPS)?
·Detect co-infection and secondary infection
·Provide first-hand information without prior pathogen information
·Full-length genome information for virus source and mutation monitoring
Dr. Yao Jiang, MGI senior product manager
If you have any questions, you can send an email to: